
Ying Liu
@YingLiu88
Followers
375
Following
130
Media
65
Statuses
131
GYN MedOnc and Clinical Genetics MSKCC | Columbia Residency | DukeMed | fighting health disparities | #tarheel for life! | opinions my own
New York, NY
Joined February 2015
RT @TeamOvary_MSK: š Big congrats to Dr. McPherson and Dr. Sohrab Shahās team on their new Nature paper!.Their work on whole-genome doublinā¦.
nature.com
Nature - A single-cell sequencing study using more than 30,000 tumour genomes from human ovarian cancers shows that whole-genome doubling is an ongoing mutational process that drives tumour...
0
6
0
So proud of @saramoufarrij1 who is teaching us all about uterine LMS under the guidance of the one and only #marteehensley! @TeamEndo_MSK @TeamOvary_MSK @MSKCancerCenter @MSK_DeptOfMed
2
8
31
Promising combo of Pembro + Olaparib in p53 aberrant/CN-H #endometrialcancer presented by @MariaRubinstein at #ASCO25! We need more biomarkers to find those long term responders. @TeamEndo_MSK @TeamOvary_MSK @MSK_DeptOfMed
1
8
23
RT @OncLive: Congratulations to Kenneth Offit, MD, MPH of @MSKCancerCenter in being the Giants of Cancer Care Prevention/Genetics inductee!ā¦.
0
1
0
RT @MSKCancerCenter: Read more about research from @AliciaLatham10 aimed to investigate the potential of Pap-derived #ctDNA (Pap-ctDNA) asā¦.
0
8
0
Check out @ariadnaroque8 and her awesome #ASCO25 poster building on work from @TeamOvary_MSK looking at #breastcancer after #ovariancancer in this with germline mutations in non-BRCA HR genes, shockingly none! @MSKCancerCenter @MSK_DeptOfMed
1
8
33
So proud of @WeillCornell resident #judywang for her hard work characterizing the germline landscape of early-onset #endometrialcancer! It is unique and needs attention #ASCO25 @TeamEndo_MSK @TeamOvary_MSK @MSK_DeptOfMed @MSKCancerCenter
1
5
22
RT @TeamOvary_MSK: We were so fortunate to have a fantastic discussion with world-renowned expert Dr. Pei Hui MD PhD regarding diagnosis anā¦.
0
3
0
RT @MSK_DeptOfMed: šØThe FDA granted accelerated approval to avutometinib & defactinib for adults with KRAS-mutated recurrent low-grade seroā¦.
0
7
0
RT @MSK_DeptOfMed: Congrats to Mark G. Kris, Kenneth Offit, David G. Pfister, and @szusmani on being inducted into the 13th Giants of Canceā¦.
0
7
0
Although we will miss her @MSKCancerCenter and in our GMO group, there are only congratulations for @ClaireFriedma19 as she embarks on the next phase of her career! @TeamEndo_MSK @TeamOvary_MSK @MSK_DeptOfMed
0
3
25
RT @meghar111: Please join us for @MSKCancerCenterās 14th Annual Lynch Syndrome Educational Workshop. šļø Tues, May 6.āļø6-8:30 PM.šZoom. Regā¦.
0
5
0
Great collaboration with #JohnChan @SutterHealth using @myriadgenetics registry data! Rates of germline mutations in uterine cancer were high (14.6%) & varied by ancestry. This large database of >35k pts verified our @TeamEndo_MSK data.
0
3
11
MUTYH: Possibly another important gene in ovarian cancer? Studies are small and more work needs to be done. Thanks #melissafrey for letting me join this work! @TeamOvary_MSK.
0
3
5
Thanks #ProfMichaelSeckl from @imperialcollege & #charingcross who shared his expertise on #gestationaltrophoblasticneoplasm (GTN) and the promise of immunotherapy! #raretumors @TeamOvary_MSK @TeamEndo_MSK @MSKCancerCenter @MSK_DeptOfMed
0
0
14
Help prevent āmissed opportunitiesā in #ovariancancer @saramoufarrij1 found 15-23% of patients w/ HGSOC had a surgery where opportunistic salpingectomy (OS) was missed. @KaraLongRoche & others are raising awareness. We need data to guide patients! @TeamOvary_MSK @MSKCancerCenter
1
3
26
Our amazing fellow #clarissalam looked at role of pre-operative imaging in #endometrialcancer and found that symptoms/physical exam were critical in low grade EC but that imaging found disease in asymptomatic patients with high grade EC @TeamEndo_MSK
0
7
29
My amazing colleague #RachelGrisham bringing novel therapies to rare cancer types! Avutometinib + Defactinib shows promise in mesonephric tumors and is moving to 2nd stage. Great moderating by @ROCearbhaill #SGO2025. @TeamOvary_MSK @TeamEndo_MSK @MSK_DeptOfMed @MSKCancerCenter
1
5
44
Exciting data presented by @BakkumGamez for a novel tampon-based screening test for #EndometrialCancer! Could have implications for those at high genetic risk and #lynchsyndrome @CGAIGC @TeamEndo_MSK.
š§6 methylated DNA marker (MDM) panel yielded high sensitivity to detect #endometrialcancer from vaginal fluid.š¤©This represents an exciting potential option to avoid painful endometrial biopsy for assessment of abnormal uterine bleeding.#SGOMtg #SGO2025 #gyncsm
1
8
24